Back to CGEM
GOLDMAN SACHS GROUP INC → CGEM
GOLDMAN SACHS GROUP INC CGEM Position History
Cullinan Therapeutics, Inc. • Healthcare
Quarters held
14
Latest value
$3.4M
Q3 2026
Peak value
$17.4M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $3.9M |
| Q2 2025 | $1.4M |
| Q3 2025 | $3.8M |
| Q3 2025 | $2.1M |
| Q4 2025 | $3.3M |
| Q4 2025 | $4.2M |
| Q4 2025 | $4.2M |
| Q4 2025 | $3.3M |
| Q1 2026 | $6M |
| Q1 2026 | $493K |
| Q2 2026 | $17.4M |
| Q2 2026 | $810K |
| Q3 2026 | $11.8M |
| Q3 2026 | $3.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $3.4M | 219.3K | — | — |
| Q3 2026 | $11.8M | 769.6K | — | — |
| Q2 2026 | $810K | 44.5K | — | — |
| Q2 2026 | $17.4M | 957.1K | — | — |
| Q1 2026 | $493K | 34.7K | — | — |
| Q1 2026 | $6M | 420.7K | — | — |
| Q4 2025 | $3.3M | 319.1K | — | — |
| Q4 2025 | $4.2M | 402.7K | — | — |
| Q4 2025 | $4.2M | 402.7K | — | — |
| Q4 2025 | $3.3M | 319.1K | — | — |
| Q3 2025 | $2.1M | 348.3K | — | — |
| Q3 2025 | $3.8M | 635.6K | — | — |
| Q2 2025 | $1.4M | 183.1K | — | — |
| Q2 2025 | $3.9M | 519.1K | — | — |
Other funds holding CGEM
$177.2M
$163.2M
$163.2M
$149.2M
$137.6M
$127.4M
$108.7M
$104.7M